Toronto, Canada

Warren Lee

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Warren Lee - Innovator in Tie2 Agonists

Introduction

Warren Lee is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medical research, particularly in the development of Tie2 agonists. His innovative work focuses on methods and compositions that can enhance treatment options for various health conditions.

Latest Patents

Warren Lee holds 1 patent for his invention titled "Methods, uses and compositions of Tie2 agonists." This patent outlines methods and uses of Tie2 agonists, either alone or in combination with antiviral agents. The disclosure emphasizes the treatment of influenza, addressing bacterial superinfections associated with influenza, and reducing lung endothelial leakage. Additionally, it provides compositions that include a Tie2 agonist and an antiviral agent, along with their respective methods and uses.

Career Highlights

Throughout his career, Warren Lee has worked with esteemed institutions such as Sunnybrook Research Institute and Unity Health Toronto. His research has contributed to advancements in medical treatments and has the potential to improve patient outcomes significantly.

Collaborations

Warren has collaborated with notable colleagues, including Daniel J Dumont and Paul Van Slyke. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Warren Lee's contributions to the field of medical research through his patent on Tie2 agonists highlight his role as an influential inventor. His work not only addresses critical health issues but also paves the way for future advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…